Home / Indicator library / Biotechnology and Medical Care / Shangya (6130) overview
Shangya (6130) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Shangya, on one pageShangya (6130) snapshot, key figures
Price / earnings
—
Price / book
—
Dividend yield
0.00%
Revenue YoY (2026-06)
70.9%
Monthly revenue (2026-06)
TWD 0.02bn
Sector
Biotechnology and Medical Care
Values above are the official-source snapshot for Shangya (6130) on 2026-08-03. We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.
Seven-dimension checkup for this ticker →
Valuation river
→Loading…
Financial quality
→Loading…
Revenue growth
→Loading…
Ownership structure
→Loading…
Events, last 90 days
→Loading…
Yield river
→Loading…
Valuation models
→Loading…
Adjusted-price candles
→Loading…
6130: common questions
What is 6130's dividend yield?
6130's cash dividend yield was 0.00% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 6130's revenue growing?
6130 reported 70.9% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.
Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.